Advisor Group Holdings, Inc. Sarepta Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

$52.6 Billion
Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 4,128 shares of SRPT stock, worth $72,817. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,128

Previous 4,924 16.17%

Holding current value

$72,817

Previous $84,000 16.67%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Sep 04, 2025	SELL	$17.1 - $63.66 $13,611 - $50,673	-796 Reduced 16.17%	4,128 $70,000
Q2 2025 Aug 13, 2025	BUY	$17.1 - $63.66 $30,147 - $112,232	1,763 Added 55.77%	4,924 $84,000
Q1 2025 May 12, 2025	SELL	$63.82 - $127.89 $304,549 - $610,291	-4,772 Reduced 60.15%	3,161 $201,000
Q4 2024 Jun 06, 2025	BUY	$104.54 - $137.94 $157,437 - $207,737	1,506 Added 47.64%	4,667 $567,000
Q4 2024 Feb 07, 2025	BUY	$104.54 - $137.94 $21,744 - $28,691	208 Added 2.69%	7,933 $964,000
Q3 2024 Nov 13, 2024	BUY	$124.33 - $156.75 $581,740 - $733,433	4,679 Added 153.61%	7,725 $964,000
Q2 2024 Aug 13, 2024	SELL	$113.33 - $163.85 $338,856 - $489,911	-2,990 Reduced 49.54%	3,046 $481,000
Q1 2024 May 10, 2024	SELL	$93.7 - $141.53 $51,253 - $77,416	-547 Reduced 8.31%	6,036 $781,000
Q4 2023 Feb 12, 2024	SELL	$67.31 - $124.76 $497,084 - $921,352	-7,385 Reduced 52.87%	6,583 $634,000
Q3 2023 Nov 13, 2023	SELL	$102.5 - $123.59 $678,550 - $818,165	-6,620 Reduced 32.15%	13,968 $1.69 Million
Q2 2023 Aug 10, 2023	SELL	$106.4 - $157.19 $433,367 - $640,234	-4,073 Reduced 16.52%	20,588 $2.36 Million
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $1.92 Million - $2.55 Million	16,332 Added 196.09%	24,661 $3.4 Million
Q4 2022 Feb 10, 2023	BUY	$100.86 - $132.13 $415,543 - $544,375	4,120 Added 97.89%	8,329 $1.08 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $14,612 - $23,013	-193 Reduced 4.38%	4,209 $464,000
Q2 2022 Aug 10, 2022	SELL	$62.69 - $88.44 $27,332 - $38,559	-436 Reduced 9.01%	4,402 $329,000
Q1 2022 May 04, 2022	SELL	$63.15 - $90.42 $123,837 - $177,313	-1,961 Reduced 28.84%	4,838 $378,000
Q3 2021 Nov 05, 2021	SELL	$65.97 - $92.48 $32,193 - $45,130	-488 Reduced 6.7%	6,799 $628,000
Q2 2021 Aug 02, 2021	BUY	$69.38 - $86.75 $40,101 - $50,141	578 Added 8.62%	7,287 $566,000
Q1 2021 May 13, 2021	BUY	$72.25 - $168.95 $101,511 - $237,374	1,405 Added 26.49%	6,709 $500,000
Q4 2020 Feb 10, 2021	SELL	$125.56 - $178.74 $127,317 - $181,242	-1,014 Reduced 16.05%	5,304 $904,000
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $75,509 - $102,369	594 Added 10.38%	6,318 $887,000
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $716,100 - $1.32 Million	-7,700 Reduced 57.36%	5,724 $917,000
Q1 2020 May 18, 2020	BUY	$82.38 - $131.64 $1.11 Million - $1.77 Million	13,424 New	13,424 $596,000

Others Institutions Holding SRPT

# of Institutions

450

Shares Held

82.3M

Call Options Held

5.61M

Put Options Held

4.17M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.54B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Sarepta Therapeutics, Inc. Transaction History